NewLink Genetics Corp (NASDAQ:NLNK)

1.59
Delayed Data
As of Apr 18
 +0.02 / +1.27%
Today’s Change
1.28
Today|||52-Week Range
5.61
+4.61%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close1.57
Today’s open1.57
Day’s range1.54 - 1.63
Volume265,258
Average volume (3 months)487,907
Market cap$63.0M
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+37.34%
Earnings growth (this year)+44.79%
Earnings growth (next 5 years)+15.33%
Revenue growth (last year)-56.55%
P/E ratioNM
Price/Sales4.53
Price/Book0.55

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...+0.02+4.47%
AGRXAgile Therapeutics I...-0.03-2.13%
ISEEIVERIC bio Inc+0.02+1.44%
ZSANZosano Pharma Corp-0.09-2.58%
Data as of 8:00pm ET, 04/18/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$12.5M
Annual profit (last year)-$53.6M
Net profit margin-429.65%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Chief Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts